A Novel Equation for Estimating Sodium Intake in Peritoneal Dialysis.
NCT ID: NCT05955417
Last Updated: 2023-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2023-07-31
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Equation for Estimating Resting Energy Expenditure in Dialysis Patients
NCT04947839
Novel Equation for Estimating Intraperitoneal Pressure
NCT05313841
Daily Sodium Intake in Anuric Hemodialysis Patients and Interdialytic Weight Gain
NCT02792530
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
NCT06597201
The Study of Association Between Intradialysis Sodium Balance and Clinical Outcomes in Chronic Hemodialysis Patients
NCT02487004
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-80 years old.
* No residual renal function (urine volume\<200ml/day).
* Continuous ambulatory peritoneal dialysis or manual intermittent peritoneal dialysis.
Exclusion Criteria
* Acute systemic infection, cardio-cerebrovascular complications and surgical trauma in the past month.
* Uncorrected hyponatremia (blood sodium\<130mmol/L).
* Prescribed with sodium bicarbonate and other drugs containing sodium.
* Prescribed with glucocorticoids and aldosterone antagonists.
* Dysfunction of peritoneal dialysis catheter.
* Malignant tumor receiving radiotherapy and chemotherapy, severe dyspepsia or eating disorder.
* Body fluid loss due to vomit, diarrhea, massive sweating, or other causes.
* Cannot follow the research scheme.
* Refuse to participate in this study.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Jie
Director of PD center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jie Dong, Professor
Role: PRINCIPAL_INVESTIGATOR
Peking University First Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022SF38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.